Clinical context

Cataract surgery outcomes are not defined by best-corrected visual acuity alone. Refractive accuracy, vision at different distances, spectacle dependence, contrast sensitivity, dysphotopsia and procedural safety all matter. Corneal and macular status, capsular support, cataract density and IOL calculation also shape the final result. A statistically convincing average therefore still has to be interpreted against the characteristics of an individual eye.

What was studied

This post-hoc analysis of a prospective series compared five formulas after secondary implantation of a one-piece IOL with sutureless intrascleral fixation. SRK/T, Hoffer Q and Holladay 1 were assessed in 226 eyes; Barrett Universal II and Kane in 187. Outcomes were prediction error, mean absolute error and proportions within ±0.50 and ±1.00 D. An OCT subgroup of 86 eyes examined IOL tilt and decentration.

How the evidence was produced

A cohort study describes how outcomes are associated with an exposure or treatment in an observed clinical population. This design is useful for routine practice, uncommon events and longer follow-up, but it remains vulnerable to confounding by indication, baseline risk differences and missing data. An association should not automatically be interpreted as a causal effect.

Key result Mean absolute error was lowest with Barrett Universal II at 0.44 ± 0.37 D and Kane at 0.46 ± 0.39 D, P<.0001. The proportions within ±0.50 D were 69.0% for Barrett, 66.3% for Kane, 53.5% for SRK/T, 52.2% for Hoffer Q and 51.3% for Holladay 1. Corresponding values within ±1.00 D were 90.9%, 90.9%, 83.6%, 83.2% and 82.3%. Errors beyond ±1.00 D were associated with axial length below 22 mm or above 26 mm, P=.022. Decentration showed no significant association.

How to interpret the result

Modern formulas handled the unusual lens position better, but even with Barrett about one third of eyes missed ±0.50 D. Short eyes tended toward myopic and long eyes toward hyperopic error. IOL tilt correlated positively with Kane error and weakly negatively with Barrett error. The findings inform counseling but do not establish a universal constant adjustment.

The result should be understood as an estimate for the population studied, not a promise of an individual outcome. Statistical and clinical significance, absolute and relative effects, and prespecified and exploratory analyses should be distinguished. When several endpoints or subgroups are reported, the prespecified primary endpoint for which the study was designed usually provides the most reliable inference.

Clinical applicability

This evidence is most useful as a basis for preoperative discussion and surgical planning. It helps identify which outcomes should be measured and which trade-offs should be explained to patients. The average effect should not be generalized to every IOL, technique or patient without checking eligibility criteria, surgeon experience, biometry, ocular comorbidity and duration of follow-up.

Limitations

This post-hoc analysis was not a prespecified randomized formula comparison. Barrett and Kane used 187 eyes while older formulas used 226, so comparison depends on missingness. The OCT subgroup had 86 eyes. Results concern one IOL and fixation method and may not transfer to a three-piece Yamane procedure. Check constant optimization, error definitions, axial-length distribution, missing data and handling of fellow eyes.

Beyond the limitations acknowledged by the authors, confidence is affected by sample size, follow-up duration, missing data, choice of comparator and relevance of the outcomes to routine care. Uncommon complications may remain undetected even in a well-conducted study. External validity is reduced when participants, equipment or investigator expertise differ substantially from everyday settings.

What to verify in the source

In the full paper, verify the protocol, eligibility criteria, baseline group characteristics, primary endpoint definition, confidence intervals, adverse events and losses to follow-up. Funding, conflicts of interest, trial registration and consistency between the published analysis and the original plan deserve separate attention. The DOI or source link below provides access to the primary publication for this check.